SF3B1 and myelodysplastic syndrome: We show that SF3B1-mutant MDS can be distinguished from other MDS using cytomorphology and blood counts alone with high predictive performance, with hypolobulated neutrophils and large RBC being more prevalent in this MDS subtype.